Expanding The Tent: Improving Trial Participation Among Under-Represented Patient Populations
New Tufts CSDD Research Creates A Baseline For Change
The biopharma industry has struggled to recruit patients into clinical trials that adequately reflect the diverse patient populations they hope to reach with new products. Failure to improve minority subgroup participation now will cost trial sponsors later.
